On August 13, 2018, President Trump signed into law the National Defense Authorization Act (NDAA) of 2019. While the annual NDAAs are tracked, analyzed, and picked apart with great care by the federal contracting community, the health care industry typically pays them little mind. But ignoring the 2019 NDAA would be a big mistake, because tucked within its more than 1,000 sections is one that will have a significant impact on many health care industry players. It’s known as Section 889. Read our thoughts on Section 889’s impact on the Health Care industry here.

See the full article here: Why the Health Care Industry Should Be Concerned About Section 889 of the 2019 National Defense Authorization Act

Photo of Christine Clements Christine Clements

Christine Clements is a partner in the Governmental Practice in the firm’s Washington, D.C. office and a member of the firm’s Healthcare Team.

Photo of Jonathan Aronie Jonathan Aronie

Jonathan Aronie is the Leader of the firm’s Governmental Practice Group and is a former Managing Partner of the Washington, D.C. office. Jonathan also is a founding member of the firm’s Organizational Integrity Group, a cross-disciplinary team of litigators, regulatory specialists, federal monitors…

Jonathan Aronie is the Leader of the firm’s Governmental Practice Group and is a former Managing Partner of the Washington, D.C. office. Jonathan also is a founding member of the firm’s Organizational Integrity Group, a cross-disciplinary team of litigators, regulatory specialists, federal monitors, and ex-prosecutors with extensive experience helping organizations prevent and defend against challenges to their organizational integrity.

Photo of Keeley A. McCarty Keeley A. McCarty

Keeley McCarty is an associate in the Governmental Practice in the firm’s Washington, D.C. office.

Photo of Michael Paddock Michael Paddock

Michael Paddock is a partner in the Governmental Practice in the firm’s Washington, D.C. office.